FDA Announces Joint Meeting of Advisory Committees for Anesthetic and Analgesic Drugs

Summary

The FDA is hosting a joint public meeting of its Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee to provide advice on regulatory issues, with public comments to be accepted via a newly established docket.